Author: Lynne Taylor

The revenue provisions of the US Senate Finance Committee’s draft health reform proposals would establish a fee of $2.3 billion to be paid every year by the drug industry, starting from 2010.

The publication of seven positive appraisals by the National Institute for Health and Clinical Excellence (NICE) led to use of the medicines involved increasing above expectations last year, while in the case of five positive appraisals the drugs’ use was lower that predicted, it was reported yesterday.

The pharmaceutical industry has made major contributions to the health of the US public, but it must also be considered part of the nation’s well-organized crime, says an industry critic.

Thousands of osteoporosis patients in England and Wales are being denied effective treatments because of guidance from the National Institute for Health and Clinical Excellence (NICE) that “defies logic,” the British Science Festival has heard.

18% of patients suffering from myelodysplastic syndromes (MDS), a type of blood cancer, could have lived longer if they had had access to drugs which are currently not approved by the National Council for Health and Clinical Excellence (NICE), a new survey reports.